Compounds > s-nitroso-n-acetylpenicillamine
Page last updated: 2024-08-16

s-nitroso-n-acetylpenicillamine and Hypertrophy

s-nitroso-n-acetylpenicillamine has been researched along with Hypertrophy in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chuang, LY; Guh, JY; Huang, JS; Hwang, JY; Kan, WC; Liu, YB; Yang, YL1
Chuang, LY; Guh, JY; Huang, JS; Huang, YJ1
Anderson, HD; Kardami, E; Louis, XL; Netticadan, T; Stringer, DM; Taylor, C; Thandapilly, SJ; Wigle, J; Yang, T; Yu, L; Zahradka, P; Zhang, S1
Bouallegue, A; Daou, GB; Srivastava, AK1

Other Studies

4 other study(ies) available for s-nitroso-n-acetylpenicillamine and Hypertrophy

ArticleYear
Angiotensin-converting enzyme inhibitors attenuated advanced glycation end products-induced renal tubular hypertrophy via enhancing nitric oxide signaling.
    Journal of cellular physiology, 2019, Volume: 234, Issue:10

    Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Enlargement; Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enalapril; Enzyme Activation; Glycation End Products, Advanced; Humans; Hypertrophy; Kidney Tubules, Proximal; MAP Kinase Signaling System; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Thionucleotides

2019
Effects of nitric oxide and antioxidants on advanced glycation end products-induced hypertrophic growth in human renal tubular cells.
    Toxicological sciences : an official journal of the Society of Toxicology, 2009, Volume: 111, Issue:1

    Topics: Antioxidants; Blotting, Western; Cell Line; Cell Size; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Fibronectins; Flow Cytometry; Glycation End Products, Advanced; Humans; Hypertrophy; Kidney Tubules; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Oncogene Protein p21(ras); Receptor for Advanced Glycation End Products; Receptors, Immunologic; S-Nitroso-N-Acetylpenicillamine

2009
Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway.
    European journal of pharmacology, 2011, Oct-01, Volume: 668, Issue:1-2

    Topics: Adenylate Kinase; Animals; Cell Size; Hypertrophy; Male; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Niacinamide; Nitric Oxide; Norepinephrine; Protein Biosynthesis; Pyrazoles; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Resveratrol; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Stilbenes

2011
Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:4

    Topics: Animals; Aorta, Thoracic; Cell Proliferation; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Inhibitors; Focal Adhesion Kinase 2; Guanylate Cyclase; Hypertrophy; Leucine; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; Oxadiazoles; Phosphorylation; Protein Biosynthesis; Proto-Oncogene Proteins c-akt; Quinoxalines; Rats; Receptors, Cytoplasmic and Nuclear; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Soluble Guanylyl Cyclase

2007